Skip Navigation

Profile

Michael D. Chan, M.D.Wake Forest Baptist Health

Doctor Rating

4.8 out of 5

170 Ratings
17 Comments
 

Michael D. Chan, M.D.

Associate Professor,

Clinical Interests

Brain Tumors

Contact Information

Returning Patient Appointments: 336-713-3600
Department: 336-713-3600

Email: mchan@wakehealth.edu

Insurance Accepted »

Education & Training

  • B.A., Johns Hopkins University, 1998
  • M.D., New York University School of Medicine, 2004

Board Certifications

  • American Board of Radiology, Radiation Oncology

NPI Number

  • 1225151152
Michael D. Chan, M.D.

Doctor Rating

4.8 out of 5

170 Ratings
17 Comments
 

Michael D. Chan, M.D.

Associate Professor, Radiation Oncology

Research Interests

Radiosurgery; Brain Neoplasms; Glioblastoma; Meningioma; Trigeminal Neuralgia
More »

Contact Information

Academic: 336-713-3600 | Department: 336-713-3600

Email: mchan@wakehealth.edu

Recent Publications

Use of non-ionizing electromagnetic fields for the treatment of cancer. Jimenez H, Blackman C, Lesser G, Debinski W, Chan M, Sharma S, Watabe K, Lo HW, Thomas A, Godwin D, Blackstock W, Mudry A, Posey J, O'Connor R, Brezovich I, Bonin K, Kim-Shapiro D, Barbault A, Pasche B.. Front Biosci (Landmark Ed). 2018;23():284-297.

Multi-institutional competing risks analysis of distant brain failure and salvage patterns after upfront radiosurgery without whole brain radiotherapy for brain metastasis. McTyre E, Ayala-Peacock D, Contessa J, Corso C, Chiang V, Chung C, Fiveash J, Ahluwalia M, Kotecha R, Chao S, Attia A, Henson A, Hepel J, Braunstein S, Chan M.. Ann Oncol. 2018;29(2):497-503.

Emerging indications for fractionated gamma knife radiosurgery. McTyre E, Helis CA, Farris M, Wilkins L, Sloan D, Hinson WH, Bourland JD, Dezarn WA, Munley MT, Watabe K, Xing F, Laxton AW, Tatter SB, Chan MD.. Neurosurgery. 2017;80(2):210-216.

Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery. McKay WH, McTyre ER, Okoukoni C, Alphonse-Sullivan NK, Ruiz J, Munley MT, Qasem S, Lo HW, Xing F, Laxton AW, Tatter SB, Watabe K, Chan MD.. J Neurosurg. 2017;127(1):148-156.

Predictors of neurologic and nonneurologic death in patients with brain metastasis initially treated with upfront stereotactic radiosurgery without whole-brain radiation therapy. McTyre ER, Johnson AG, Ruiz J, Isom S, Lucas JT Jr, Hinson WH, Watabe K, Laxton AW, Tatter SB, Chan MD.. Neuro Oncol. 2017;19(4):558-566.

Multi-institutional nomogram predicting survival free from salvage whole brain radiation after radiosurgery in patients with brain metastases. Gorovets D, Ayala-Peacock D, Tybor DJ, Rava P, Ebner D, Cielo D, Noren G, Wazer DE, Chan M, Hepel JT.. Int J Radiat Oncol Biol Phys. 2017;97(2):246-253.

Stereotactic radiosurgical treatment of glomus jugulare tumors. Winford TW, Dorton LH, Browne JD, Chan MD, Tatter SB, Oliver ER.. Otol Neurotol. 2017;38(4):555-562.

Gamma Knife radiosurgery for brain metastases from gastrointestinal primary. Page BR, Wang EC, White L, McTyre E, Peiffer A, Alistar A, Mu F, Loganathan A, Bourland JD, Laxton AW, Tatter SB, Chan MD.. J Med Imaging Radiat Oncol. 2017;61(4):522-527.

Outcomes for anaplastic glioma treated with radiation therapy with or without concurrent temozolomide. McTyre E, Lucas JT, Helis C, Farris M, Soike M, Mott R, Laxton AW, Tatter SB, Lesser GJ, Strowd RE, Lo HW, Debinski W, Chan MD.. Am J Clin Oncol. 2017;():.

The evolving role for re-irradiation in the management of recurrent grade 4 glioma. Howard SP, Krauze A, Chan MD, Tsien C, Tome WA.. J Neurooncol. 2017;134(3):523-530.

The effects of smoking status and smoking history on patients with brain metastases from lung cancer. Shenker RF, McTyre ER, Ruiz J, Weaver KE, Cramer C, Alphonse-Sullivan NK, Farris M, Petty WJ, Bonomi MR, Watabe K, Laxton AW, Tatter SB, Warren GW, Chan MD.. Cancer Med. 2017;6(5):944-952.

Leptomeningeal failure in patients with breast cancer receiving stereotactic radiosurgery for brain metastases. Wang EC, Huang AJ, Huang KE, McTyre ER, Lo HW, Watabe K, Metheny-Barlow L, Laxton AW, Tatter SB, Strowd RE, Chan MD, Page BR.. J Clin Neurosci. 2017;43():6-10.

Combined inhibition of AKT and HSF1 suppresses breast cancer stem cells and tumor growth. Carpenter RL, Sirkisoon S, Zhu D, Rimkus T, Harrison A, Anderson A, Paw I, Qasem S, Xing F, Liu Y, Chan M, Metheny-Barlow L, Pasche BC, Debinski W, Watabe K, Lo HW.. Oncotarget. 2017;8(43):73947-63.

Prediction of new brain metastases after radiosurgery: validation and analysis of performance of a multi-institutional nomogram. Ayala-Peacock DN, Attia A, Braunstein SE, Ahluwalia MS, Hepel J, Chung C, Contessa J, McTyre E, Peiffer AM, Lucas JT Jr, Isom S, Pajewski NM, Kotecha R, Stavas MJ, Page BR, Kleinberg L, Shen C, Taylor RB, Onyeuku NE, Hyde AT, Gorovets D,.. J Neurooncol. 2017;135(2):403-411.

Stereotactic radiosurgery in the treatment of brain metastases from gynecologic primary cancer. Johnston H, McTyre ER, Cramer CK, Lesser GJ, Ruiz J, Bourland JD, Watabe K, Lo HW, Qasem S, Laxton AW, Tatter SB, Chan MD.. J Radiosurg SBRT. 2017;5(1):55-61.

Impact of radiosurgical management of geriatric patients with brain metastases: clinical and quality of life outcomes. Randolph DM, McTyre E, Klepin H, Peiffer AM, Ayala-Peacock D, Lester S, Laxton AW, Dohm A, Tatter SB, Shaw EG, Chan MD.. J Radiosurg SBRT. 2017;5(1):35-42.

Early or late radiotherapy following gross or subtotal resection for atypical meningiomas: clinical outcomes and local control. Dohm A, McTyre ER, Chan MD, Fan C, Isom S, Bourland JD, Mott RT, Cramer CK, Tatter SB, Laxton AW.. J Clin Neurosci. 2017;46():90-98.

Staged stereotactic radiosurgery for large brain metastases: local control and clinical outcomes of a one-two punch technique. Dohm A, McTyre ER, Okoukoni C, Henson A, Cramer CK, LeCompte MC, Ruiz J, Munley MT, Qasem S, Lo HW, Xing F, Watabe K, Laxton AW, Tatter SB, Chan MD.. Neurosurgery. 2017;():.

DBF 2.0: A web-based predictive model for distant brain failure, brain metastasis velocity, and early death after radiosurgery for brain metastases [abstract]. Henson A, Ayala-Peacock DN, Chung C, Hepel JT, Chao ST, Contessa JN, Fiveash JB, Attia A, McTyre E, Braunstein SE, Page BR, Shen C, Kleinberg LR, Watabe K, Pasche B, D'Agostino R Jr, Chan MD.. Int J Radiat Oncol Biol Phys. 2017;99(2 Suppl):E78-E79.

Clinical outcomes of upfront stereotactic radiosurgery alone for patients with greater than 4 brain metastases [abstract]. Hughes RT, McTyre E, LeCompte MC, Cramer CK, Munley MT, Laxton A, Tatter SB, Ruiz J, Pasche B, Watabe K, Chan MD.. Int J Radiat Oncol Biol Phys. 2017;99(2 Suppl):E80-E81.

Survival and failure outcomes predicted by brain metastasis kinetics following initial distant brain failure in melanoma patients treated upfront with stereotactic radiosurgery alone [abstract]. LeCompte MC, McTyre E, Henson A, Farris M, Okoukoni C, Cramer CK, Triozzi P, Munley MT, Qasem S, Xing F, Watabe K, Laxton A, Tatter SB, Chan MD.. Int J Radiat Oncol Biol Phys. 2017;99(2 Suppl):E86-E87.

Multi-institutional validation of brain metastasis velocity, a recently defined predictor of outcomes following stereotactic radiosurgery [abstract]. McTyre E, Farris M, Ayala-Peacock DN, Page BR, Shen C, Kleinberg LR, Contessa JN, Chung C, Ruiz J, Pasche B, Watabe K, Fiveash JB, Hepel JT, Chao ST, Braunstein SE, Attia A, Chan MD.. Int J Radiat Oncol Biol Phys. 2017;99(2 Suppl):E93.

Using a novel machine learning technique to predict brain metastasis velocity following stereotactic radiosurgery for brain metastases [abstract]. Muhlestein W, Farris M, McTyre E, Pajewski NM, Attia A, Chambless LB, Braunstein SE, Hepel JT, Chung C, Contessa JN, Chao ST, Fiveash JB, Chan MD, Ayala-Peacock DN.. Int J Radiat Oncol Biol Phys. 2017;99(2 Suppl):E96.

Drivers of the cost of management in patients treated with radiosurgery without whole brain radiation therapy for brain metastases [abstract]. Shenker RF, McTyre E, Cramer CK, Munley MT, Ruiz J, Watabe K, Pasche B, Laxton A, Tatter SB, Chan MD.. Int J Radiat Oncol Biol Phys. 2017;99(2 Suppl):E414-E415.

Using a novel machine learning technique to predict radiation oncology outcomes [abstract]. Muhlestein W, Chambless LB, Pajewski NM, Braunstein SE, Hepel JT, Chung C, Contessa JN, Chao ST, Fiveash JB, Attia A, Chan MD, Ayala-Peacock DN.. Int J Radiat Oncol Biol Phys. 2017;99(2 Suppl):E422-E423.

Determination of tumor gene expression in non-small cell lung cancer patients who develop brain metastasis diagnosis: analysis of a prospective trial [abstract]. Dohm AE, Su J, McTyre E, Soike M, Miller LD, Petty WJ, Xing F, Lo HW, Metheny-Barlow L, Watabe K, Chan MD, Ruiz J, Pasche B.. Int J Radiat Oncol Biol Phys. 2017;99(2 Suppl):E453.

Stereotactic radiosurgery for multiple sclerosis associated trigeminal neuralgia [abstract]. Helis CA, McTyre E, Munley MT, Bourland JD, Cramer CK, Laxton A, Tatter SB, Chan MD.. Int J Radiat Oncol Biol Phys. 2017;99(2 Suppl):E512-E513.

Initial brain metastasis velocity: does the rate at which cancers first seed the brain affect outcomes? [abstract]. Soike M, McTyre E, Farris M, Hughes RT, Cramer CK, LeCompte MC, Ruiz J, Bourland JD, Munley MT, Laxton A, Tatter SB, Chan MD.. Int J Radiat Oncol Biol Phys. 2017;99(2 Suppl):S170.

Expert consensus on re-irradiation for recurrent glioma. Krauze A, Attia A, Braunstein S, Chan M, Combs S, Fietkau R, Fiveash J, Flickinger J, Grosu A, Howard S, Nieder C, Niyazi M, Rowe L, Smart DD, Tsien C, Camphausen K.. Radiat Oncol. 2017;12(1):194.

A multi-institutional pilot study of prophylactic cranial tumor-treating fields for patients with extensive-stage small cell lung cancer [abstract]. Rana N, Jaboin JJ, Chan MD, Attia A.. Neuro Oncol. 2017;19(Suppl 6):26-27.

CE7 Canadian clinical trials group / alliance for clinical trials in oncology. A phase III trial of stereotactic radiosurgery compared with whole brain radiotherapy (WBRT) for 5-15 brain metastases [abstract]. Roberge D, Brown P, Mason W, O'Callaghan C, Ding KY, Whitton A, Chan MD.. Neuro Oncol. 2017;19(Suppl 6):49.

Sociodemographic predictors of patients with brain metastases treated with stereotactic radiosurgery. Alphonse-Sullivan N, Taksler GB, Lycan T, Weaver KE, McTyre ER, Shenker RF, Page BR, Isom S, Johnson A, Munley MT, Laxton AW, Tatter SB, Watabe K, Chan MD, Ruiz J.. Oncotarget. 2017;8(60):101055-11.

Hippocampal dose volume histogram predicts Hopkins Verbal Learning Test scores after brain irradiation. Okoukoni C, McTyre ER, Ayala Peacock DN, Peiffer AM, Strowd R, Cramer C, Hinson WH, Rapp S, Metheny-Barlow L, Shaw EG, Chan MD.. Adv Radiat Oncol. 2017;2(4):624-629.

The number of prior lines of systemic therapy as a prognostic factor for patients with brain metastases treated with stereotactic radiosurgery: results of a large single institution retrospective analysis. Lanier CM, McTyre E, LeCompte M, Cramer CK, Hughes R, Watabe K, Lo HW, O'Neill S, Munley MT, Laxton AW, Tatter SB, Ruiz J, Chan MD.. Clin Neurol Neurosurg. 2017;165():24-28.

Survival and failure outcomes predicted by brain metastasis volumetric kinetics in melanoma patients following upfront treatment with stereotactic radiosurgery alone. LeCompte MC, McTyre E, Henson A, Farris M, Okoukoni C, Cramer CK, Triozzi P, Ruiz J, Watabe K, Lo HW, Munley MT, Laxton AW, Tatter SB, Zhou X, Chan M.. Cureus. 2017;9(12):1-12.

Biology and treatment of metastasis of sarcoma to the brain. Ahmad O, Chan M, Savage P, Watabe K, Lo HW, Qasem S.. Front Biosci (Elite Ed). 2016;8():233-244.

Recent advances in radiosurgical management of brain metastases. Devoid HM, McTyre ER, Page BR, Metheny-Barlow L, Ruiz J, Chan MD.. Front Biosci (Schol Ed). 2016;8():203-214.

Treatment of brain metastases of lung cancer in the era of precision medicine. Haughton ME, Chan MD, Watabe K, Bonomi M, Debinski W, Lesser GJ, Ruiz J.. Front Biosci (Elite Ed). 2016;8():219-232.

Targeting the sonic hedgehog signaling pathway: review of smoothened and GLI inhibitors. Rimkus TK, Carpenter RL, Qasem S, Chan M, Lo HW.. Cancers (Basel). 2016;8(2):E22.

Pseudo progression identification of glioblastoma with dictionary learning. Zhang J, Yu H, Qian X, Liu K, Tan H, Yang T, Wang M, Li KC, Chan MD, Debinski W, Paulsson A, Wang G, Zhou X.. Comput Biol Med. 2016;73():94-101.

Identification of biomarkers for pseudo and true progression of GBM based on radiogenomics study. Qian X, Tan H, Zhang J, Liu K, Yang T, Wang M, Debinskie W, Zhao W, Chan MD, Zhou X.. Oncotarget. 2016;7(34):55377-94.

Activation of the c-Met pathway mobilizes an inflammatory network in the brain microenvironment to promote brain metastasis of breast cancer. Xing F, Liu Y, Sharma S, Wu K, Chan MD, Lo HW, Carpenter RL, Metheny-Barlow LJ, Zhou X, Qasem SA, Pasche B, Watabe K.. Cancer Res. 2016;76(17):4970-4980.

Brain metastasis velocity: a novel prognostic metric predictive of overall survival and freedom from whole-brain radiation therapy after upfront radiosurgery alone for brain metastases [abstract]. Farris M, McTyre E, Hughes RT, Ayala-Peacock DN, Randolph DM II, Bourland JD, Tatter SB, Laxton AW, Watabe K, Ruiz J, Li W, Zhou X, Chan MD.. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):S180.

Outcomes for metastatic melanoma treated with stereotactic radiosurgery in the era of targeted systemic therapies [abstract]. Henson A, McTyre E, Ayala-Peacock DN, Triozzi P, Savage P, Laxton AW, Chan MD.. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):E135-E136.

Multi-institutional competing risks analysis predicting distant brain failure and salvage patterns after upfront radiosurgery without whole-brain radiation therapy for brain metastasis [abstract]. McTyre E, Ayala-Peacock DN, Contessa JN, Chung C, Fiveash JB, Ahluwalia M, Kotecha R, Chao ST, Attia A, Hepel JT, Braunstein SE, Chan MD.. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):S180-S181.

Hippocampal dosimetry predicts for cancer-related cognitive impairment in patients treated with cranial radiation therapy: dosimetric results of a prospective clinical trial [abstract]. Okoukoni C, McTyre E, Peiffer AM, Hinson W, Strowd RE, Rapp S, Chan MD.. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):S90-S91.

Toxicity results of a phase 1 safety study of pioglitazone as a cytoprotective agent against radiation-induced cognitive decline [abstract]. Sullivan NA, Page BR, Peiffer AM, Isom S, Metheny-Barlow L, Brown DR, Blackstock AW, Chan MD.. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):E595.

Genomic predictors of imaging response and survival in glioblastoma [abstract]. Soike M, McTyre E, Holmes JA, Paulsson AK, Miller L, Lesser GJ, Strowd RE, Johnson A, Lo HW, Laxton AW, Tatter SB, Debinski W, Chan MD.. Int J Radiat Oncol Biol Phys. 2016;96(2 Suppl):E121-E122.

A phase II clinical trial of CPI-613 in patients with relapsed or refractory small cell lung carcinoma. Lycan TW, Pardee TS, Petty WJ, Bonomi M, Alistar A, Lamar ZS, Isom S, Chan MD, Miller AA, Ruiz J.. PLoS One. 2016;11(10):e0164244.

Local control of brain metastases after stereotactic radiosurgery: the impact of whole brain radiotherapy and treatment paradigm. Hughes RT, Black PJ, Page BR, Lucas JT, Qasem SA, Watabe K, Ruiz J, Laxton AW, Tatter SB, Debinski W, Chan MD.. J Radiosurg SBRT. 2016;4(2):89-96.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Associate Professor, Radiation Oncology

Clinical Interests

Brain Tumors
Michael D. Chan, M.D.

Michael D. Chan, M.D.

Associate Professor, Radiation Oncology

Doctor Rating

4.8 out of 5

Michael D. Chan, M.D.170 Ratings
17 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.9
CP efforts to include in decisions
4.9
CP explanations of prob/condition
4.9
CP spoke using clear language
4.9
Friendliness/courtesy of CP
4.9
Likelihood of recommending CP
4.9
Patients' confidence in CP
4.9
Time CP spent with patient
4.8
Wait time at clinic
4.4



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

3/21/2018

Dr Chan is terrific

3/1/2018

Awesome experience.

2/7/2018

First time I ever discussed my problem with someone who has seen and treated similar many times before. Several misunderstandings on my part that were never properly explained by previous physicians were cleared up. Difficult to describe the relief after 6 years of seeking answers to talk with several doctors and staff with such experience and understanding.

12/10/2017

Dr.Chan is a very compassionate and knowledgeable professional.

12/1/2017

Excellent staff, everybody who saw me that day treated me well and with a lot of care and concern

11/8/2017

Dr. Chan was very courteous and was very helpful in everything . He was the first Dr. to encourage me with things going on .

9/29/2017

Dr. Chan was helpful in a problem I was having. He is very understanding and compassionate.

9/6/2017

Dr. Chan is the best!

8/18/2017

*Dr. Chan is very thorough doctor - He is very _____ and caring. He treats you as a person not a number!

8/4/2017

*Dr. Chan is a wonderful doctor. He is always very kind also his staff. I am bless to have him as my doctor.

7/30/2017

A very professional care provider.We would recommend him to anyone.

7/27/2017

Dr Chan and his team are awesome. Dr Chan is probably the only person I do trust. he's been honest and up front with me about my condition from day 1. I adore him

7/17/2017

very good

6/20/2017

Dr. Chan was very professional and informative.

5/30/2017

Dr Chan is definitely the A team at Winston Salem

5/17/2017

Dr Chan was exceptional throughout.

5/13/2017

Dr. Chan is caring and compassionate.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Six Wake Forest Baptist Specialties Earn U.S. News RankingsComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsNursing Magnet StatusJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.